輸入代號或公司名稱後按 Enter
4737

華廣

+0.10 (+0.17%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
58.4078成交張數本益比2.15股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.68-4.05-0.53-12.5%-2.48%-14.38%
2026Q1-1.09-3.58-0.80-19.7%-4.05%-12.13%
2025Q4-1.39-2.68-0.92-21.6%-5.14%-9.95%
2025Q3-0.89-1.78-0.61-13.2%-3.24%-6.52%
2025Q2-0.22-1.68-0.15-3.1%-0.78%-6.03%
2025Q1-0.19-1.99-0.13-2.6%-0.67%-7.12%
2024Q4-0.49-384.2%-1.88-0.33-6.5%-1.75%-6.58%
2024Q3-0.79-1.22-0.54-11.0%-2.89%-4.39%
2024Q2-0.53-446.9%-0.58-0.36-7.5%-1.89%-2.06%
2024Q1-0.070.10-0.05-1.1%-0.26%0.35%
2023Q40.17-57.8%0.090.112.3%0.58%0.31%
2023Q3-0.15-200.0%0.32-0.10-2.4%-0.52%1.12%
2023Q20.15-73.8%0.630.112.5%0.54%2.16%
2023Q1-0.08-139.2%1.06-0.06-1.4%-0.28%3.66%
2022Q40.40-13.5%1.350.284.6%1.35%4.40%
2022Q30.15-66.7%1.410.101.8%0.51%4.68%
2022Q20.58195.6%1.720.396.9%1.97%5.76%
2022Q10.2115.0%1.330.142.9%0.68%4.39%
2021Q40.47-32.5%1.300.326.6%1.55%4.23%
2021Q30.46-25.0%1.530.316.2%1.53%5.01%
2021Q20.201.680.133.2%0.65%5.62%
2021Q10.181.260.122.6%0.57%3.96%
2020Q40.69-19.8%0.950.458.9%2.21%3.04%
2020Q30.61580.4%1.120.409.0%2.04%3.67%
2020Q2-0.22-137.3%0.60-0.15-4.1%-0.74%1.96%
2020Q1-0.13-216.7%1.43-0.08-2.3%-0.40%4.46%
2019Q40.86-10.3%1.660.557.4%2.77%5.27%
2019Q30.09-77.8%1.760.061.2%0.30%5.80%
2019Q20.6042.5%2.080.386.7%1.94%6.92%
2019Q10.11-50.0%1.900.071.9%0.34%5.90%
2018Q40.9632.1%2.000.619.9%3.13%6.28%
2018Q30.40-44.4%1.770.264.7%1.36%5.75%
2018Q20.42-4.1%2.090.276.0%1.35%6.87%
2018Q10.22-41.5%2.110.143.6%0.66%6.02%
2017Q40.73-28.3%2.260.478.2%2.30%6.41%
2017Q30.73-5.8%2.550.4710.8%2.32%7.67%
2017Q20.44-22.2%2.600.296.9%1.30%8.07%
2017Q10.37105.0%2.720.266.8%1.03%7.66%
2016Q41.022.530.7213.6%2.82%
2016Q30.770.5412.2%2.18%